These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8459261)

  • 41. The pathway-specific regulatory genes, tei15* and tei16*, are the master switches of teicoplanin production in Actinoplanes teichomyceticus.
    Horbal L; Kobylyanskyy A; Truman AW; Zaburranyi N; Ostash B; Luzhetskyy A; Marinelli F; Fedorenko V
    Appl Microbiol Biotechnol; 2014 Nov; 98(22):9295-309. PubMed ID: 25104028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug interaction: rifampicin and glibenclamide.
    Surekha V; Peter JV; Jeyaseelan L; Cherian AM
    Natl Med J India; 1997; 10(1):11-2. PubMed ID: 9069698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbial de-mannosylation and mannosylation of teicoplanin derivatives.
    Borghi A; Ferrari P; Gallo GG; Zanol M; Zerilli LF; Lancini GC
    J Antibiot (Tokyo); 1991 Dec; 44(12):1444-51. PubMed ID: 1838104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors affecting the normal and branched-chain acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus.
    Borghi A; Edwards D; Zerilli LF; Lancini GC
    J Gen Microbiol; 1991 Mar; 137(3):587-92. PubMed ID: 1827835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbiological profile of teicoplanin.
    Covelli I; Nani E
    J Chemother; 1991 Jan; 3 Suppl 1():39-42. PubMed ID: 12041783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
    Lefort A; Arthur M; Depardieu F; Chau F; Pouzet C; Courvalin P; Fantin B
    J Infect Dis; 2004 Jan; 189(1):90-7. PubMed ID: 14702158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S; Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycopeptide resistance determinants from the teicoplanin producer Actinoplanes teichomyceticus.
    Serina S; Radice F; Maffioli S; Donadio S; Sosio M
    FEMS Microbiol Lett; 2004 Nov; 240(1):69-74. PubMed ID: 15500981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of teicoplanin on the chemiluminescence of phagocytosing human granulocytes.
    Aquilini D; Bartoloni A; Paradisi F
    J Chemother; 1991 Jan; 3 Suppl 1():119-21. PubMed ID: 12041744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. V. Aromatic constituents.
    Coronelli C; Bardone MR; DePaoli A; Ferrari P; Tuan G; Gallo GG
    J Antibiot (Tokyo); 1984 Jun; 37(6):621-6. PubMed ID: 6235205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Todd PG; Hinks L; Lloyd B; Alberti KG
    Diabetologia; 1977 Apr; 13(2):145-52. PubMed ID: 404205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Campoli-Richards DM; Brogden RN; Faulds D
    Drugs; 1990 Sep; 40(3):449-86. PubMed ID: 2146108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gliflumide, a new oral antidiabetic of high potency and efficacy.
    Blumenbach L; Gerhards E; Gutsche H; Klein W; Loge O; Losert W; Schillinger E; Speck U; Vetter H; Wendt H
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):141-51. PubMed ID: 809367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis.
    Aslangul E; Baptista M; Fantin B; Depardieu F; Arthur M; Courvalin P; Carbon C
    J Infect Dis; 1997 Mar; 175(3):598-605. PubMed ID: 9041331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review of teicoplanin in the treatment of serious neonatal infections.
    Fanos V; Kacet N; Mosconi G
    Eur J Pediatr; 1997 Jun; 156(6):423-7. PubMed ID: 9208233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Teicoplanin: a new glycopeptide antibiotic complex.
    Babul N; Pasko M
    Drug Intell Clin Pharm; 1988 Mar; 22(3):218-26. PubMed ID: 2966729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Teicoplanin and its influence on Staphylococcus aureus ultrastructure.
    Tullio V; Cuffini AM; Carlone NA
    J Chemother; 1991 Jan; 3 Suppl 1():89-92. PubMed ID: 12041797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin.
    Schall R; Müller FO; Hundt HK; Ritter W; Duursema L; Groenewoud G; Middle MV
    J Clin Pharmacol; 1995 Mar; 35(3):306-13. PubMed ID: 7608323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats].
    Zhao HF; Sun JH; Liu S; Liu Y; Liu GF
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):982-988. PubMed ID: 28994544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.